INS and type 1 diabetes mellitus: Autoantibodies emerge against various beta-cell antigens, such as insulin, glutamate decarboxylase, islet antigen 2, and zinc transporter 8, several years before the clinical disease manifestation, and the risk of T1D correlates with the number of beta-cell autoantibodies.